FPH is one of those safe stocks imo where instos etc park their funds until buying signals appear of other beaten up stocks to rebuy, top up , load up on.
Printable View
FPH is one of those safe stocks imo where instos etc park their funds until buying signals appear of other beaten up stocks to rebuy, top up , load up on.
And that's exactly the time when FPH's shares will drop ... just imagine a flock of instos pushing the sell button and retail shareholders noticing that they sit on a share with a backward PE of 135 while other shares at that stage might be available for single digit PE's. It is as well probably the time when everybody in the world has lots of idle ventilators sitting around - and no, they won't need that many of the masks either.
The trick will be to sell close to, but prior to this point in time.
I thought that we had established that FPH's forte is humidifiers, not ventilators?
Well, sure. Just ask yourself why their business is booming that much at the moment.
If the reasons for this boom are in any way connected to the current virus boom, than I am wondering why they should survive the latter?
Of course will FPH still have business afterwards, but it will return from the current boom to its normal growth path, and at that stage the SP might look really dear.
Don't forget that the NZD has weakened a lot against the USD, and hence it'll benefit FPH's bottom line.
Only around 15%? of Covid 19 patients hospitalized need ventilators
There are a lot of benefits using F & P therapies for Covid 19 patients
https://www.fphcare.com/nz/covid-19/
Nasal High Flow Therapy
Using Optiflow™ Nasal High Flow to treat COVID‑19 patients.
Heated Humidification
The use of heated humidification for healthcare professionals managing COVID‑19 patients.
Efficiency of Filters and F&P Evaqua™ 2
The viral and bacterial filtration efficiency of Fisher & Paykel Healthcare Filters and F&P Evaqua™ 2 Circuits.
Noninvasive (NIV) Therapy
Using Noninvasive (NIV) therapy to treat COVID-19 patients.
Optiflow THRIVE™ Product Conversion
Adapting existing Fisher & Paykel Healthcare products to treat COVID-19 patients.
CPAP Therapy for OSA
COVID-19 and CPAP therapy for Obstructive Sleep Apnea: Guidance for CPAP Users and Healthcare Professionals.
Remember:88 % of hospital revenue are consumables,recurring revenue,only 12% is hardware
https://resources.fphcare.com/resour...ear-update.pdf